Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2013 Jul 29;90(1061):171–178. doi: 10.1136/postgradmedj-2013-203726rep

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions

This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 3.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/3.0/

PMC Copyright notice

Sources of possible biomarkers in osteoarthritis.^10–20 C2C, cleavage of type II collagen; C2M, collagen type II-specific neoepitope; C3M, collagen type III-specific neoepitope; Coll 2-1, 9-amino acid peptide of type II collagen (nitrated form Coll 2-1 NO₂); COMP, cartilage oligomeric protein; CPII, type II collagen propeptide; CRP, C reactive protein; CTX, C-terminal telopeptide of collagen; DKK, wnt inhibitor; FSTL-1, follistatin-like protein 1; ICTP, type I collagen-derived cross-linked carboxy-terminal telopeptide; IL, interleukin; MMP, matrix metalloproteinase; NTX, N-terminal telopeptide of collagen OPG, osteoprotegerin; PIIANP, N-propeptide IIA of type II collagen; PIIBNP, N-propeptide IIB of type II collagen; PIICP, C-propeptide of collagen type II; PINP, N-propeptide of type I collagen; PIINP, N-propeptide of type II collagen; RANK-L, receptor activator of nuclear factor κB ligand; RAGE, receptor for advanced glycation endproducts; TNF, tumour necrosis factor.